Selection and Development of Nontoxic Nonproteolytic

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

1. Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia.Toxins · 2023
   Review
2. Potential Risk of Botulinum Neurotoxin -producing Clostridia Occurrence in Canned Fish.Journal of veterinary research · 2022
   Article
3. Genomic Diversity, Competition, and Toxin Production by Group I and IIMicroorganisms · 2022
   Article
4. First cross-border outbreak of foodborne botulism in the European Union associated with the consumption of commercial dried roach (Frontiers in public health · 2022
   Article
5. Frontiers in microbiology · 2022
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors at 2 institutions in 2 countries.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as